封面
市場調查報告書
商品編碼
1691789

視網膜剝離診斷市場 - 全球產業規模、佔有率、趨勢、機會和預測,按疾病類型、診斷方法、地區和競爭細分,2020-2030 年預測

Retinal Detachment Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Disease Type, By Diagnostics, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球視網膜剝離診斷市場價值為 21 億美元,預計在預測期內將呈現強勁成長,到 2030 年的複合年成長率為 5.45%。全球視網膜剝離診斷市場是更廣泛的眼科和眼保健領域中的重要部分,主要著重於視網膜剝離的診斷和早期發現—視網膜剝離是一種威脅視力的疾病,視網膜剝離下層組織。該市場涵蓋醫療保健專業人員用來識別和評估視網膜剝離和相關疾病的各種診斷工具、技術和服務。

市場概況
預測期 2026-2030
2024 年市場規模 21億美元
2030 年市場規模 28.9 億美元
2025-2030 年複合年成長率 5.45%
成長最快的領域 眼底照相
最大的市場 北美洲

由於幾個關鍵因素,全球視網膜剝離診斷市場一直穩定成長。隨著全球老化人口的增加,視網膜剝離和其他視網膜疾病的盛行率上升,從而推動了對診斷服務和設備的需求。此外,人們對眼部健康的認知不斷增強,以及定期眼部檢查的重要性,促使人們尋求早期診斷和治療,從而促進市場成長。

診斷設備的技術進步大大提高了視網膜剝離診斷的準確性和效率。光學相干斷層掃描 (OCT)、眼底照相和超音波等高解析度成像技術徹底改變了該領域,使醫療保健專業人員能夠更精確地檢測視網膜異常。這反過來又促進了早期介入並改善了患者的治療效果。

主要市場促進因素

視網膜疾病盛行率不斷上升

主要市場挑戰

成本限制

主要市場趨勢

遠距醫療和遠端監控

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第 4 章:顧客之聲

第 5 章:視網膜剝離診斷市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依疾病類型(孔源性視網膜剝離、滲出性、漿液性或繼發性視網膜剝離、牽引性視網膜剝離)
    • 依診斷(眼底照相、檢眼鏡檢查、數位視網膜照相機、螢光視網膜血管攝影、其他)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第 6 章:北美視網膜剝離診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 加拿大
    • 墨西哥

第 7 章:歐洲視網膜剝離診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章:亞太地區視網膜剝離診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章:南美洲視網膜剝離診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲視網膜剝離診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 13 章:全球視網膜剝離診斷市場:SWOT 分析

第 14 章:競爭格局

  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec Inc.
  • Revenio Group Corporation (Centervue SpA)
  • Eyenuk Inc.
  • Essilor International SA
  • HealPros LLC
  • Millennium Surgical Corp.
  • ONL Therapeutics
  • Peek Vision Ltd
  • Parata Systems (Synergy Medical) LLC

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 17567

Global Retinal Detachment Diagnostic Market was valued at USD 2.10 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.45% through 2030. The Global Retinal Detachment Diagnostics Market is a crucial segment within the broader ophthalmology and eye care sector, primarily focusing on the diagnosis and early detection of retinal detachment-a sight-threatening condition where the retina peels away from the underlying tissue. This market encompasses various diagnostic tools, technologies, and services used by healthcare professionals to identify and assess retinal detachment and related disorders.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.10 Billion
Market Size 2030USD 2.89 Billion
CAGR 2025-20305.45%
Fastest Growing SegmentFundus Photography
Largest MarketNorth America

The Global Retinal Detachment Diagnostics Market has been steadily growing due to several key factors. As the aging population increases worldwide, the prevalence of retinal detachment and other retinal disorders rises, thereby driving the demand for diagnostic services and equipment. Additionally, the growing awareness of eye health and the importance of regular eye check-ups have prompted individuals to seek early diagnosis and treatment, contributing to market growth.

Technological advancements in diagnostic devices have significantly improved the accuracy and efficiency of retinal detachment diagnosis. High-resolution imaging techniques like Optical Coherence Tomography (OCT), fundus photography, and ultrasound have revolutionized the field, enabling healthcare professionals to detect retinal abnormalities with greater precision. This, in turn, fosters early intervention and improved patient outcomes.

Key Market Drivers

Increasing Prevalence of Retinal Disorders

The growing prevalence of retinal disorders is a major driver fueling the expansion of the global retinal detachment diagnostic market. As the incidence of vision-related diseases continues to rise worldwide, the demand for early detection, accurate diagnosis, and preventive screening has increased significantly. This trend is primarily driven by factors such as the rising diabetic population, aging demographics, increased cases of high myopia, and lifestyle-related ocular diseases. Diabetes is one of the most significant risk factors for retinal detachment, as it leads to diabetic retinopathy-a condition that damages retinal blood vessels and can progress to tractional retinal detachment (TRD) if left untreated. According to the IDF Diabetes Atlas (2021), 10.5% of the global adult population (aged 20-79 years) is affected by diabetes, with nearly 50% of cases going undiagnosed. This silent health crisis has significant implications for healthcare systems and diagnostic markets worldwide.

Projections indicate a 46% surge in diabetes cases by 2045, with 1 in 8 adults-approximately 783 million people-expected to be diabetic. This rapid escalation will drive higher demand for early screening technologies, retinal diagnostics, and preventive healthcare solutions, positioning the ophthalmic diagnostics sector for substantial growth in the coming decades. As diabetic patients are advised to undergo routine eye examinations, the demand for advanced retinal imaging diagnostics such as Optical Coherence Tomography (OCT), Fundus Photography, and Fluorescein Angiography has grown exponentially. Many governments and healthcare organizations have implemented diabetic eye screening initiatives to prevent vision loss, further driving demand for retinal diagnostic devices. As diabetes cases continue to surge, the retinal detachment diagnostic market is witnessing higher adoption of diagnostic technologies across hospitals, clinics, and telemedicine platforms.

The aging global population is a significant contributor to the rising prevalence of retinal detachment and related disorders. Older individuals are more prone to posterior vitreous detachment (PVD), a common precursor to retinal detachment. As life expectancy increases, age-related macular degeneration (AMD) is becoming a leading cause of vision impairment, requiring frequent retinal monitoring. In elderly individuals, the vitreous gel inside the eye shrinks, leading to retinal tears and detachment, increasing the demand for early diagnostic imaging. By 2050, an estimated 80% of the global elderly population will reside in low- and middle-income countries, signaling a demographic shift with profound economic and healthcare implications.

Key Market Challenges

Cost Constraints

One of the significant challenges facing the growth of the Global Retinal Detachment Diagnostic market is cost constraints. State-of-the-art diagnostic technologies, such as Optical Coherence Tomography (OCT) and high-resolution fundus cameras, are integral to accurate retinal detachment diagnosis. These advanced technologies often come with a substantial price tag. The cost of acquiring, maintaining, and upgrading such equipment can be prohibitive for smaller healthcare facilities and clinics, limiting their ability to provide comprehensive retinal diagnostics. In many regions, healthcare budgets are limited, and healthcare providers must allocate resources across various medical specialties. As a result, ophthalmology departments may struggle to secure funding for the purchase and maintenance of expensive retinal diagnostic equipment. This limitation can lead to inadequate access to retinal examinations in underserved areas. Reimbursement policies and rates for retinal diagnostic tests can vary significantly by country and region. In some cases, reimbursement may not cover the full cost of the diagnostic procedure, leaving healthcare providers with financial burdens. This can discourage facilities from investing in advanced retinal diagnostics and hinder market growth.

Key Market Trends

Telemedicine and Remote Monitoring

Advances in telemedicine technology have enabled ophthalmologists and retinal specialists to conduct virtual consultations with patients. Through video conferencing and digital imaging, healthcare providers can assess retinal health, monitor progression, and offer guidance remotely. This trend has become particularly important during the COVID-19 pandemic when in-person visits were limited. The emergence of wearable devices, such as smartphone-based fundus cameras and portable OCT devices, allows patients to capture retinal images at home. These images can be securely transmitted to healthcare providers for assessment. This trend not only enhances patient convenience but also facilitates early detection and continuous monitoring of retinal conditions. The data generated through telemedicine and remote monitoring can be analyzed using artificial intelligence (AI) algorithms. AI-powered software can assist in the early identification of retinal abnormalities and trends, improving diagnostic accuracy and enabling timely interventions. This data-driven approach is expected to play a pivotal role in the future of retinal diagnostics.

Key Market Players

  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec Inc.
  • Revenio Group Corporation (Centervue SpA)
  • Eyenuk Inc.
  • Essilor International SA
  • HealPros LLC
  • Millennium Surgical Corp.
  • ONL Therapeutics
  • Peek Vision Ltd
  • Parata Systems (Synergy Medical) LLC

Report Scope:

In this report, the Global Retinal Detachment Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Retinal Detachment Diagnostic Market, By Disease Type:

  • Rhegmatogenous Retinal Detachment
  • Exudative
  • Serous or Secondary Retinal Detachment
  • Tractional Retinal Detachment

Retinal Detachment Diagnostic Market, By Diagnostics:

  • Fundus Photography
  • Ophthalmoscopy
  • Digital Retinal Camera
  • Fluorescent Retinal Angiography
  • Others

Retinal Detachment Diagnostic Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Retinal Detachment Diagnostic Market.

Available Customizations:

Global Retinal Detachment Diagnostic market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Retinal Detachment Diagnostic Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Disease Type (Rhegmatogenous Retinal Detachment, Exudative, Serous or Secondary Retinal Detachment, Tractional Retinal Detachment)
    • 5.2.2. By Diagnostics (Fundus Photography, Ophthalmoscopy, Digital Retinal Camera, Fluorescent Retinal Angiography, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Retinal Detachment Diagnostic Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Disease Type
    • 6.2.2. By Diagnostics
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Retinal Detachment Diagnostic Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Disease Type
        • 6.3.1.2.2. By Diagnostics
    • 6.3.2. Canada Retinal Detachment Diagnostic Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Disease Type
        • 6.3.2.2.2. By Diagnostics
    • 6.3.3. Mexico Retinal Detachment Diagnostic Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Disease Type
        • 6.3.3.2.2. By Diagnostics

7. Europe Retinal Detachment Diagnostic Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Disease Type
    • 7.2.2. By Diagnostics
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Retinal Detachment Diagnostic Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Disease Type
        • 7.3.1.2.2. By Diagnostics
    • 7.3.2. United Kingdom Retinal Detachment Diagnostic Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Disease Type
        • 7.3.2.2.2. By Diagnostics
    • 7.3.3. Italy Retinal Detachment Diagnostic Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Disease Type
        • 7.3.3.2.2. By Diagnostics
    • 7.3.4. France Retinal Detachment Diagnostic Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Disease Type
        • 7.3.4.2.2. By Diagnostics
    • 7.3.5. Spain Retinal Detachment Diagnostic Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Disease Type
        • 7.3.5.2.2. By Diagnostics

8. Asia-Pacific Retinal Detachment Diagnostic Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Disease Type
    • 8.2.2. By Diagnostics
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Retinal Detachment Diagnostic Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Disease Type
        • 8.3.1.2.2. By Diagnostics
    • 8.3.2. India Retinal Detachment Diagnostic Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Disease Type
        • 8.3.2.2.2. By Diagnostics
    • 8.3.3. Japan Retinal Detachment Diagnostic Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Disease Type
        • 8.3.3.2.2. By Diagnostics
    • 8.3.4. South Korea Retinal Detachment Diagnostic Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Disease Type
        • 8.3.4.2.2. By Diagnostics
    • 8.3.5. Australia Retinal Detachment Diagnostic Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Disease Type
        • 8.3.5.2.2. By Diagnostics

9. South America Retinal Detachment Diagnostic Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Disease Type
    • 9.2.2. By Diagnostics
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Retinal Detachment Diagnostic Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Disease Type
        • 9.3.1.2.2. By Diagnostics
    • 9.3.2. Argentina Retinal Detachment Diagnostic Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Disease Type
        • 9.3.2.2.2. By Diagnostics
    • 9.3.3. Colombia Retinal Detachment Diagnostic Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Disease Type
        • 9.3.3.2.2. By Diagnostics

10. Middle East and Africa Retinal Detachment Diagnostic Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Disease Type
    • 10.2.2. By Diagnostics
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Retinal Detachment Diagnostic Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Disease Type
        • 10.3.1.2.2. By Diagnostics
    • 10.3.2. Saudi Arabia Retinal Detachment Diagnostic Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Disease Type
        • 10.3.2.2.2. By Diagnostics
    • 10.3.3. UAE Retinal Detachment Diagnostic Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Disease Type
        • 10.3.3.2.2. By Diagnostics

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Retinal Detachment Diagnostic Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Canon Medical Systems Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Carl Zeiss Meditec Inc.
  • 14.3. Revenio Group Corporation (Centervue SpA)
  • 14.4. Eyenuk Inc.
  • 14.5. Essilor International SA
  • 14.6. HealPros LLC
  • 14.7. Millennium Surgical Corp.
  • 14.8. ONL Therapeutics
  • 14.9. Peek Vision Ltd
  • 14.10.Parata Systems (Synergy Medical) LLC

15. Strategic Recommendations

16. About Us & Disclaimer